Anna Nikkarinen
PhD student at Department of Immunology, Genetics and Pathology; Research programme: Cancer Precision Medicine; Research group Ingrid Glimelius
- E-mail:
- anna.nikkarinen@igp.uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala - Postal address:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala
Short presentation
Anna is a specialist in oncology and a researcher in Ingrid Glimelius research team at IGP. She defended her thesis called From Macrophages to Mutations: Tumour Microenvironment and Genetic Evolution in Mantle Cell Lymphoma in february 2026.
Her research is translational, with a focus on tumour microenvironment and genetics in mantle cell lymphoma.
Keywords
- cancer genetics
- cancer immunotherapy
- mantelcellslymfom
- makrofager
Publications
Selection of publications
-
Part of British Journal of Haematology, p. 520-531, 2021
- DOI for Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors
- Download full text (pdf) of Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors
Recent publications
-
Part of Leukemia, p. 681-684, 2026
-
From Macrophages to Mutations: Tumour Microenvironment and Genetic Evolution in Mantle Cell Lymphoma
2026
-
Part of RMD Open, 2025
- DOI for Targeted proteomics identifies differentially expressed proteins in Sjögren's disease with incident lymphoma
- Download full text (pdf) of Targeted proteomics identifies differentially expressed proteins in Sjögren's disease with incident lymphoma
-
Part of eJHaem, p. 820-824, 2024
- DOI for Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma: A case report
- Download full text (pdf) of Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma: A case report
-
Part of Blood Advances, p. 4370-4385, 2024
- DOI for CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression
- Download full text (pdf) of CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression
All publications
Articles in journal
-
Part of Leukemia, p. 681-684, 2026
-
Part of RMD Open, 2025
- DOI for Targeted proteomics identifies differentially expressed proteins in Sjögren's disease with incident lymphoma
- Download full text (pdf) of Targeted proteomics identifies differentially expressed proteins in Sjögren's disease with incident lymphoma
-
Part of eJHaem, p. 820-824, 2024
- DOI for Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma: A case report
- Download full text (pdf) of Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma: A case report
-
Part of Blood Advances, p. 4370-4385, 2024
- DOI for CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression
- Download full text (pdf) of CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression
-
Part of Blood Advances, p. 5304-5313, 2023
-
Part of British Journal of Haematology, p. 520-531, 2021
- DOI for Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors
- Download full text (pdf) of Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors